Issued Patents All Time
Showing 25 most recent of 82 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12378556 | Treatment of angiopoietin like 7 (ANGPTL7) related diseases | Omri GOTTESMAN, Shannon BRUSE, Paul BUSKE, Brian CAJES, David L. Lewis | 2025-08-05 |
| 12312586 | Treatment of MST1 related diseases and disorders | Omri GOTTESMAN, Shannon BRUSE, Paul BUSKE, Brian CAJES, David JAKUBOSKY +3 more | 2025-05-27 |
| 12258563 | Modified oligonucleotides | Darren H. Wakefield, Lauren J. Almeida, Omri GOTTESMAN, David L. Lewis | 2025-03-25 |
| 12258564 | GalNAc compositions for improving siRNA bioavailability | Darren H. Wakefield, Omri GOTTESMAN | 2025-03-25 |
| 12116573 | Targeting ligands for therapeutic compounds | Darren H. Wakefield, Andrei V. Blokhin, Jonathan D. Benson, Zhen Li, Tao Pei +1 more | 2024-10-15 |
| 11879125 | GalNAc compositions for improving siRNA bioavailability | Darren H. Wakefield, Omri GOTTESMAN | 2024-01-23 |
| 11840688 | Compositions and methods for inhibiting gene expression of Hif2alpha | So Wong, David L. Lewis, Darren H. Wakefield, Steven B. Kanner, Weijun Cheng +7 more | 2023-12-12 |
| 11666588 | Prodrugs of ALOX-15 inhibitors and methods of using the same | Omri GOTTESMAN, Shannon BRUSE, Brian CAJES, David L. Lewis | 2023-06-06 |
| 11590156 | RNAi agents for hepatitis B virus infection | Zhen Li, Rui Zhu, Christine I. Wooddell, Bruce D. Given, Tao Pei +3 more | 2023-02-28 |
| 11534453 | RNAi therapy for hepatitis B virus infection | Christine I. Wooddell, David L. Lewis, Darren H. Wakefield, Lauren J. Almeida | 2022-12-27 |
| 11517584 | RNAi agents for Hepatitis B virus infection | Zhen Li, Rui Zhu, Christine I. Wooddell, Bruce D. Given, Tao Pei +3 more | 2022-12-06 |
| 11452738 | Treatment of thymic stromal lymphopoietin (TSLP) related diseases by inhibition of long-form TSLP transcripts | Omri GOTTESMAN, Shannon BRUSE, Brian CAJES, David L. Lewis | 2022-09-27 |
| 11377658 | Oligonucleotides for treatment of angiopoietin like 4 (ANGPTL4) related diseases | Omri GOTTESMAN, Shannon BRUSE, Brian CAJES, David L. Lewis | 2022-07-05 |
| 11174480 | Post-transcriptionally chemically modified double strand RNAs | Juan P. Arhancet, Sreevishnu Cheerla, Graciela B. Arhancet | 2021-11-16 |
| 11116778 | Prodrugs of ALOX-15 inhibitors and methods of using the same | Omri GOTTESMAN, Shannon BRUSE, Brian CAJES, David L. Lewis | 2021-09-14 |
| 10941404 | Treatment of angiopoietin like 7 (ANGPTL7) related diseases | Omri GOTTESMAN, Shannon BRUSE, Paul BUSKE, Brian CAJES, David L. Lewis | 2021-03-09 |
| 10927373 | Compositions and methods for inhibiting gene expression of Hif2alpha | So Wong, David L. Lewis, Darren H. Wakefield, Steven B. Kanner, Weijun Cheng +7 more | 2021-02-23 |
| 10806750 | RNAi therapy for hepatitis B virus infection | Christine I. Wooddell, David L. Lewis, Darren H. Wakefield, Lauren J. Almeida | 2020-10-20 |
| 10780108 | RNAi agents for Hepatitis B virus infection | Zhen Li, Rui Zhu, Christine I. Wooddell, Bruce D. Given, Tao Pei +3 more | 2020-09-22 |
| 10662427 | Compositions and methods for inhibiting gene expression of LPA | Stacey Melquist, Steven B. Kanner, David L. Lewis, Lauren J. Almeida, Darren H. Wakefield +4 more | 2020-05-26 |
| 10640769 | Post-transcriptionally chemically modified double strand RNAs | Juan P. Arhancet, Sreevishnu Cheerla, Graciela B. Arhancet | 2020-05-05 |
| 10316316 | Compositions for targeted delivery of siRNA | David L. Lewis, Darren H. Wakefield, Torsten Hoffman, Erik Kitas, Peter Mohr +3 more | 2019-06-11 |
| 10246709 | Targeting ligands for therapeutic compounds | Darren H. Wakefield, Andrei V. Blokhin, Jonathan D. Benson, Zhen Li, Tao Pei +1 more | 2019-04-02 |
| 10130651 | RNAi Therapy for Hepatitis B Virus Infection | Christine I. Wooddell, David L. Lewis, Darren H. Wakefield, Lauren J. Almeida | 2018-11-20 |
| 10131911 | Post-transcriptionally chemically modified double strand RNAs | Juan P. Arhancet, Sreevishnu Cheerla, Graciela B. Arhancet | 2018-11-20 |